NYXH
Nyxoah SA (NYXH)
Healthcare • NASDAQ • $1.62+3.18%
Key Fundamentals
- Symbol
- NYXH
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $1.62
- Daily Change
- +3.18%
- Market Cap
- $159.88M
- Trailing P/E
- N/A
- Forward P/E
- -1.32
- 52W High
- $8.59
- 52W Low
- $1.26
- Analyst Target
- $8.36
- Dividend Yield
- N/A
- Beta
- 0.89
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Company websiteResearch NYXH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.